Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
Posaconazole Plus Pembrolizumab and Chemotherapy vs Pembrolizumab and Chemotherapy in Neoadjuvant Therapy for Triple Negative Breast Cancer
ClinicalTrials.gov study NCT06802757. IPD Sharing: YES. Countries: 1. Publications: 0.
Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Patients
ClinicalTrials.gov study NCT04159818. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase Ib Study of Novel Combination (New) of Low Dose Oral CyclophoSphamide (s) to Potentiate Axatilimab (A) + Retifanlimab (R) in Treating Metastatic Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT06959537. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer
ClinicalTrials.gov study NCT07281976. IPD Sharing: NO. Countries: 1. Publications: 0.
FMT in Triple Negative Breast Cancer Guided by ctDNA
ClinicalTrials.gov study NCT07292142. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Ant
ClinicalTrials.gov study NCT06926868. IPD Sharing: YES. Countries: 28. Publications: 0.
Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT01939418. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Paclitaxel for Injection (Albumin Bound) in Subjects With Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT04405505. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT02183805. IPD Sharing: NO. Countries: 1. Publications: 0.
Mutation of BRCA1/2 and Other Potential Genes in Triple-negative Breast Cancer
ClinicalTrials.gov study NCT02670668. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of BMN-673 With Carboplatin and Paclitaxel in Patients With Advanced BRCA-mutated Solid Tumor or Triple Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT02358200. IPD Sharing: NO. Countries: 1. Publications: 0.
S-equol in Women With Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02352025. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PD-1(Programmed Death-1) Antibody +GP as First Line Treatment for Triple Negative Breast Cancer(TNBC) Patients
ClinicalTrials.gov study NCT03251313. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Addition of Vismodegib to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Patients
ClinicalTrials.gov study NCT02694224. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients
ClinicalTrials.gov study NCT02348281. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Pilot Surveillance Study to Monitor Natural Killer Cells and Circulating Tumor Cells in Women With Previously Treated Non-metastatic Triple Negative Breast Cancer and Women With Previously Treated N
ClinicalTrials.gov study NCT02639832. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT01238133. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer
ClinicalTrials.gov study NCT06631092. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer
ClinicalTrials.gov study NCT04768426. IPD Sharing: NO. Countries: 1. Publications: 0.
Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer
ClinicalTrials.gov study NCT06976944. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.